252852 Secondhand Smoke: Prevalence, Validation and Effects

Monday, October 31, 2011: 5:30 PM

Brittny Major, BS , Epidemiology and Public Health, University of Miami, Miller School of Medicine, Miami, FL
Manuel A. Ocasio, BA , Department of Epidemiology and Public Health, University of Miami, Miller School of Medicine, Miami, FL
Alberto J. Caban-Martinez, PhD, DO, MPH, CPH , Department of Epidemiology & Public Health, University of Miami, Miller School of Medicine - NIOSH Research Group, Miami, FL
Kristopher L. Arheart, EdD , Department of Epidemiology & Public Health, University of Miami, Miller School of Medicine - NIOSH Research Group, Miami, FL
Jaime Forrest, MS , Bereau of Epidemiology, Florida Department of Health, Tallahassee, FL
Melissa Jordan, MS , Bureau of Epidemiology, Florida Department of Health, Tallahassee, FL
Kimberly Cohen, JD, MSW , Bureau of Epidemiology, Florida Department of Health, Tallahassee, FL
Youjie Huang, MD, DrPH , Bureau of Epidemiology, Florida Department of Health, Tallahassee, FL
Tainya Clarke, MPH, MS , Department of Epidemiology & Public Health, University of Miami, Miller School of Medicine, Miami, FL
Noella Dietz, PhD , Department of Epidemiology and Public Health, University of Miami, Leonard Miller School of Medicine, Miami, FL
Jennifer J. Hu, PhD , Department of Epidemiology and Public Health, University of Miami Miller School of Medicine, Miami, FL
Lora E. Fleming, MD, PhD , European Centre for Environment and Human Health (PCMD) and Univesity of Miami OHH Center and NIOSH Research Group, Miami, FL
David J. Lee, PhD , Epidemiology and Public Health, University of Miami, Miller School of Medicine, Miami, FL
The US Surgeon General has reported that secondhand smoke (SHS) exposure has deleterious health effects. However, individuals are frequently unaware of their SHS exposure and well validated self-report measures are not readily available. The aim of this study is to validate self-reported SHS exposure by comparing reported responses with salivary cotinine and hair nicotine levels. This study is currently in its pilot phase. A telephone interview assessing a range of SHS exposure sources, respiratory symptoms and quality of life as measured by the EuroQol-5D has been completed in 100 self-reported non-smokers recruited from the Florida 2010 Behavioral Risk Factor Surveillance System Study. Following the interview, each participant was asked to mail a hair and saliva sample to the research office in the prepaid envelope provided. Participants were re-interviewed and re-sampled in order to determine test-retest reliability. Average self-reported secondhand smoke exposure time is 2.18 hours/day. Respiratory symptom questions based on the previous 30 days demonstrated good reliability; weighted kappa statistics ranged from 0.40-0.77. Twelve-month history of respiratory disorders and EQ5D measures also exhibited good reliability with weighted kappa statistics ranging from 0.54-1.00 and 0.50-0.71 respectively.Results indicate that test-retest reliability of SHS exposure, respiratory symptom and EQ-5D measures meet established standards of validity for survey research. The next critical phase of the pilot will be to correlate exposure, disease and quality of life measures with biomarkers of SHS exposure to establish a short and valid protocol for assessing exposure in population-based studies where collection of biological samples is unfeasible.

Learning Areas:
Basic medical science applied in public health
Epidemiology
Public health or related laws, regulations, standards, or guidelines
Public health or related research

Learning Objectives:
To validate self-reported SHS exposure by comparing responses with salivary cotinine and hair nicotine levels and to document health outcomes associated with these exposures To assess the reliability of test-retest survey responses on secondhand smoke exposure.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a Master's of Public Health student that has worked primarily in the data collection and analysis for this abstract.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

See more of: Epidemiologic Methods
See more of: APHA-Student Assembly